The {pharmaceutical market is rapidly exploring novel treatment strategies for obesity , and the arrival of semaglutide 10mg injectables represents a change. Healthcare professionals are cautiously assess the possible benefits and drawbacks associated with this stronger strength product, notably in contrast with existing lower-dose semaglutide medi